Jme Group Associates INC

Their homepage, crawled JUL 31, 2026

At a glance

EmployeesNot reported

In business sinceNot reported

Industry

Dog and Cat Food Manufacturing

HeadquartersRoseland, NJ

SAM.gov UEIH1MQFMYFRPJ7

JME Group is a biotechnology company that develops oral enzyme replacement therapy and non-viral gene replacement therapy for metabolic and lysosomal storage diseases in humans and animals. The company produces recombinant human enzymes using plant-derived sources, specifically recombinant human lysosomal acid alpha-glucosidase produced in tobacco seeds for treatment of Pompe disease. The company serves patients with rare orphan diseases, particularly those with Pompe disease and acid maltase deficiency.

Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.